Table 5.
Association between systemic manifestations and various antinuclear antibodies
| ANA antibodi es | Tested results | Musculos keletal system Present (%) | Gastroint estinal system Present (%) | Respiratory system Present (%) | Cardiova scular system Present (%) | Renal system Present (%) | Centralnervous system Present (%) |
|---|---|---|---|---|---|---|---|
| Anti-dsDNA | Positive | 12 (40%) | 3 (10%) | 4 (13%) | 1 (3%) | 5 (16%) | 0 (0%) |
| Negative | 8 (26%) | 7 (23%) | 7 (23%) | 2 (6%) | 7 (23%) | 7 (23%) | |
| P | 0.038* | 0.196 | 0.386 | 0.626 | 0.654 | 0.005 | |
| Anti Sm | Positive | 4 (13%) | 3 (10%) | 2 (7%) | 0 (0%) | 6 (20%) | 7 (23%) |
| Negative | 16 (53%) | 7 (23%) | 9 (30%) | 3 (10%) | 6 (20%) | 0 (0%) | |
| P | 0.243 | 0.77 | 0.424 | 0.271 | 0.018* | 0.001* | |
| Anti SCL 70 | Positive | 5 (16%) | 4 (13%) | 6 (20%) | 2 (6%) | 1 (3%) | 0 (0%) |
| Negative | 15 (50%) | 6 (20%) | 5 (16%) | 1 (3%) | 11 (33%) | 7 (23%) | |
| P | 0.77 | 0.243 | 0.009* | 0.099 | 0.064 | 0.068 | |
| Anti SS-A | Positive | 3 (10%) | 2 (6%) | 1 (3%) | 2 (6%) | 3 (10%) | 2 (6%) |
| Negative | 17 (57%) | 8 (27%) | 10 (33%) | 1 (3%) | 9 (30%) | 5 (16%) | |
| P | 0.729 | 0.702 | 0.397 | 0.014* | 0.317 | 0.334 |
*Indicates correlation